FDA Inspection 710017 — Guardian Drug Co. Inc.

Guardian Drug Co. Inc. — FEI 2245306

The FDA completed an inspection of Guardian Drug Co. Inc. on February 18, 2011 in Dayton, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 18, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Dayton, NJ (United States)

Citations

IDCFRDescription
121521 CFR 211.67(b)Written procedures not established/followed
191421 CFR 211.166(a)Lack of written stability program
360321 CFR 211.160(b)Scientifically sound laboratory controls
363921 CFR 211.204Returned drug procedures in writing and followed